Osaki, T <br/><br/>
IFN-gamma-inducing factor/IL-18 administration mediates IFN-gamma- and IL-12-independent antitumor effects.  [electronic resource] 

 -  Journal of immunology (Baltimore, Md. : 1950)  Feb 1998 
 - 1742-9 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0022-1767 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adjuvants, Immunologic--physiology<br/>Animals<br/>Antineoplastic Agents--administration & dosage<br/>CD4-CD8 Ratio--drug effects<br/>CD8-Positive T-Lymphocytes--drug effects<br/>Cytokines--administration & dosage<br/>Cytotoxicity, Immunologic<br/>Fibrosarcoma--immunology<br/>G(M1) Ganglioside--immunology<br/>Gene Deletion<br/>Growth Inhibitors--administration & dosage<br/>Immune Sera--pharmacology<br/>Injections, Intraperitoneal<br/>Interferon Inducers--administration & dosage<br/>Interferon-gamma--blood<br/>Interleukin-10--blood<br/>Interleukin-12--administration & dosage<br/>Interleukin-18<br/>Killer Cells, Natural--immunology<br/>Lymphocyte Depletion<br/>Melanoma, Experimental--immunology<br/>Mice<br/>Mice, Inbred C57BL<br/>Mice, Knockout<br/>Neoplasm Transplantation<br/>Sarcoma, Experimental--immunology<br/>Tumor Cells, Cultured